{"id":70699,"date":"2026-05-12T09:19:23","date_gmt":"2026-05-12T09:19:23","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70699"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"selank","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/selank\/","title":{"rendered":"Selank"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 o Selank?<\/h3>\n<p style=\"margin: 0;\"><strong>Selank<\/strong> is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">129954-34-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">751.88 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Thr-Lis-Pro-Arg-Pro-Gli-Pro-NH<sub>2<\/sub> (TKPRPGP-NH<sub>2<\/sub>, 7 amino\u00e1cidos; an\u00e1logo amidado na extremidade C-terminal da tuftsina)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (branco a branco sujo)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar no prazo de ~30 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O Que \u00c9 o Selank?<\/h2>\n<p><strong>Selank<\/strong> is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a>. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank&#8217;s well-characterised sequence is TKPRPGP-NH<sub>2<\/sub>, peso molecular 751,88 Da, f\u00f3rmula emp\u00edrica C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> p\u00e1gina de produto. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Vias GABA\u00e9rgicas, Serotonin\u00e9rgicas e de BDNF<\/h2>\n<p>What makes Selank distinctive among anxiolytic compounds is its <strong>perfil de neuromodula\u00e7\u00e3o multi-vias<\/strong> sem liga\u00e7\u00e3o direta ao recetor GABA<sub>A<\/sub> benzodiazepine site \u2014 each contributing to the observed anxiolytic and nootropic phenotype in published studies:<\/p>\n<ul>\n<li><strong>Modula\u00e7\u00e3o GABA\u00e9rgica sem liga\u00e7\u00e3o ao local das benzodiazepinas<\/strong> \u2014 Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank&#8217;s pharmacology.<\/li>\n<li><strong>Sinaliza\u00e7\u00e3o serotonin\u00e9rgica e encefalin\u00e9rgica<\/strong> \u2014 Published studies has documented increased serotonin metabolism (5-HIAA \/ 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.<\/li>\n<li><strong>Express\u00e3o de BDNF e neuroplasticidade<\/strong> \u2014 Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank&#8217;s nootropic profile \u2014 improved memory consolidation and learning performance in rodent maze tasks.<\/li>\n<\/ul>\n<p>Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Selank is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Farmacologia ansiol\u00edtica<\/strong> \u2014 testes de labirinto em cruz elevado, campo aberto e intera\u00e7\u00e3o social em modelos de roedores com ansiedade generalizada; bra\u00e7os comparativos contra benzodiazepinas (diazepam) e SSRIs (Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)<\/li>\n<li><strong>Stress resilience and HPA-axis studies<\/strong> \u2014 modelos de stress cr\u00f3nico leve, stress por conten\u00e7\u00e3o e desamparo aprendido; din\u00e2mica do cortisol e ACTH<\/li>\n<li><strong>BDNF and neuroplasticity studies<\/strong> \u2014 express\u00e3o de BDNF no hipocampo e c\u00f3rtex pr\u00e9-frontal, morfologia das espinhas dendr\u00edticas, eletrofisiologia da potencia\u00e7\u00e3o a longo prazo<\/li>\n<li><strong>Cognitive and memory studies<\/strong> \u2014 Labirinto aqu\u00e1tico de Morris, reconhecimento de objeto novo, esquiva passiva; efeitos nootr\u00f3picos independentes de ansiolise<\/li>\n<li><strong>Imunomodula\u00e7\u00e3o<\/strong> \u2014 Selank inherits tuftsin&#8217;s immunomodulatory activity, with documented effects on cytokine balance (TNF-\u03b1, IL-6, IFN-\u03b3) and macrophage function in published studies<\/li>\n<li><strong>Comparative studies vs benzodiazepines<\/strong> \u2014 Compara\u00e7\u00e3o direta com diazepam, alprazolam e fenazepam quanto \u00e0 efic\u00e1cia ansiol\u00edtica, potencial de depend\u00eancia e reca\u00edda; o perfil de abstin\u00eancia limpo do Selank \u00e9 um dos resultados mais citados na literatura russa<\/li>\n<li><strong>Sister-peptide studies<\/strong> \u2014 compara\u00e7\u00e3o com <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.<\/li>\n<\/ul>\n<p>For broader context on small-peptide neuromodulation and nootropic studies, see <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> como o comparador nootr\u00f3pico can\u00f3nico desenvolvido na R\u00fassia, <a href=\"https:\/\/medsbase.com\/pt-pt\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> for the parallel small-peptide healing-compound. Browse the full <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para encontrar compostos relacionados. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, intranasal-vehicle formulation studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols. <\/p>\n<h2>Compara\u00e7\u00e3o \u2014 Selank vs Semax<\/h2>\n<p>Selank e <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic\/neuroprotective. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Semax<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (heptapept\u00eddeo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (heptapept\u00eddeo)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>P\u00e9ptido parental<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tuftsina (TKPR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fragmento de ACTH(4-10)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo prim\u00e1rio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Modula\u00e7\u00e3o de GABA, BDNF, encefalina<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BDNF, recetores de melanocortina, dopamina<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico, resili\u00eancia ao stress<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootr\u00f3pico, neuroprotetor, foco<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 mcg\/dia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u20131.000 mcg\/dia<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico russo<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico aprovado (intranasal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootr\u00f3pico aprovado \/ recupera\u00e7\u00e3o de AVC (intranasal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stacking in studies<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frequentemente combinado com Semax para efeito ansiol\u00edtico+nootr\u00f3pico complementar<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frequentemente combinado com Selank<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because the two peptides act on complementary axes \u2014 Selank on GABA\/anxiolytic, Semax on melanocortin\/dopaminergic\/nootropic \u2014 they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazenar frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para stock de trabalho a curto prazo. Para armazenamento a longo prazo sem abertura, congelar a \u221220 \u00b0C. O Selank liofilizado \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o at\u00e9 24 meses e a \u221220 \u00b0C at\u00e9 36 meses. Evitar ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3 liofilizado. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 1.0\u00a0mL of bacteriostatic water yields a 5\u00a0mg\/mL working concentration; 0.1\u00a0mL delivers a 500\u00a0mcg dose. Swirl gently \u2014 do <strong>n\u00e3o<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138\u00a0\u00b0C e utilize dentro de 30 dias para estabilidade \u00f3tima. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam a integridade do p\u00e9ptido. Descarte qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is Selank used for in studies?<\/h3>\n<p>Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is <strong>n\u00e3o<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>Em que \u00e9 que o Selank difere do Semax?<\/h3>\n<p>Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways \u2014 canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation \u2014 canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping. <\/p>\n<h3>What is the typical Selank dose?<\/h3>\n<p>Published Russian protocols typically use 300\u2013900\u00a0mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5\u00a0mg vial reconstituted with 1.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 0.1\u00a0mL equals 500\u00a0mcg, a typical single-dose studies aliquot. <\/p>\n<h3>O Selank \u00e9 aprovado pela FDA?<\/h3>\n<p>No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez). <\/p>\n<h3>Como deve ser armazenado o Selank?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para stock de trabalho a curto prazo, ou \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, utilizar no prazo de 30 dias. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam o p\u00e9ptido. Proteger da luz direta em todos os momentos. <\/p>\n<h3>Como devo reconstituir o Selank?<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado), agite suavemente e aguarde 2 a 5 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> Agite o frasco. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 transparente e incolor. Para um frasco de 5 mg + 1,0 mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 5 mg\/mL. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>MedsBase carries Selank in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Selank be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models. <\/p>\n<h3>Can Selank and Semax be stacked in studies?<\/h3>\n<p>Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA\/enkephalin\/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin\/dopaminergic\/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress. <\/p>\n<h3>Does Selank cause side reported effects?<\/h3>\n<p>Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation \u2014 in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review. <\/p>\n<h3>Qual \u00e9 a meia-vida do Selank?<\/h3>\n<p>In preclinical studies, Selank has an estimated plasma half-life of approximately 15\u201330 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance. <\/p>\n<h3>How long does Selank take to show effects in preclinical studies?<\/h3>\n<p>Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30\u201360 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7\u201314 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models. <\/p>\n<h3>Posso encomendar Selank para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia Selank para todo o mundo a partir da nossa rede dedicada de envio de pept\u00eddeos. As encomendas exclusivas de pept\u00eddeos qualificam-se para o nosso servi\u00e7o de envio de pept\u00eddeos independente. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura, com rastreio completo e est\u00e3o cobertas pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Garantia de Reenvio<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Sister heptapeptide from the same Russian clinical \u2014 nootropic and neuroprotective studies<\/li>\n<li><a href=\"\/pt-pt\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/pt-pt\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<li><a href=\"\/pt-pt\/kpv-lysine-proline-valine\/\"><strong>KPV<\/strong><\/a> \u2014 Small immunomodulatory tripeptide \u2014 inflammation and barrier studies<\/li>\n<li><a href=\"\/pt-pt\/adamax\/\"><strong>Adamax<\/strong><\/a> \u2014 Heptapeptide nootropic compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore small-peptide nootropic studies<\/strong><\/p>\n<p style=\"margin: 0;\">Explore a gama completa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, com compostos relacionados incluindo <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> for melanocortin-axis nootropic studies, <a href=\"https:\/\/medsbase.com\/pt-pt\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/pt-pt\/adamax\/\">Adamax<\/a> for sister heptapeptide cognitive studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Ansiol\u00edtico sem seda\u00e7\u00e3o<br \/>\n\u2705 Modula\u00e7\u00e3o multi-vias de GABA \/ BDNF \/ encefalina<br \/>\n\u2705 Stress-resilience compound<br \/>\n\u2705 Pept\u00eddeo com biodisponibilidade intranasal<br \/>\n\u2705 Perfil de descontinua\u00e7\u00e3o mais limpo comparado com benzodiazepinas<\/p>\n<p><strong>Selank<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70977,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,6273],"class_list":["post-70699","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-selank","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/70699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=70699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70977"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=70699"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=70699"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=70699"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=70699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}